M1A.2521 Drug-induced chronic gout, left hip, with tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Left Hip, with Tophus (tophi)

Summary

Drug-induced chronic gout, left hip, with tophus (tophi) is a form of arthritis affecting the left hip joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and the presence of tophi (urate crystal deposits) in the affected area.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the left hip joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense left hip pain, often with swelling and redness
• Persistent warmth and tenderness in the affected hip
• Formation of tophi (hard, painless lumps) around the hip joint
• Stiffness and limited range of motion in the left hip
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests assess uric acid levels, while joint fluid analysis may identify urate crystals. Imaging (e.g., X-rays, ultrasound) can detect tophi or joint damage. The presence of tophi and a history of medication use support the diagnosis.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatory drugs for flare-ups. Tophi may require surgical removal in severe cases. Lifestyle modifications, such as dietary changes, may also be recommended.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is essential to monitor uric acid levels and adjust treatment. Untreated or poorly managed cases may lead to progressive joint damage and disability.

Complications

• Chronic joint damage and deformity
• Persistent pain and reduced mobility
• Increased risk of kidney stones or renal impairment
• Infection of tophi (rare)

Lifestyle & Prevention

• Avoid medications known to raise uric acid levels when possible
• Maintain a balanced diet low in purines (e.g., limit red meat, alcohol)
• Stay hydrated to support uric acid excretion
• Follow prescribed treatment plans consistently

When to Seek Professional Help

Seek medical attention if you experience severe or worsening left hip pain, swelling, or stiffness, or if tophi appear or change. Prompt care is important to prevent complications and adjust treatment as needed.

Tips for Medical Coders

Document the presence of tophi and the left hip involvement clearly. Ensure the drug-induced etiology is specified, as this distinguishes the condition from other gout types. Code M1A.2521 is specific to drug-induced chronic gout with tophus in the left hip; verify laterality and tophus presence match the clinical record.